Back to Results
First PageMeta Content
Dosage forms / Pharmaceutical industry / Polymers / Chemical engineering / Tablet / Cellulose acetate phthalate / Pharmaceutical formulation / Excipient / Absorption / Pharmaceutical sciences / Pharmacology / Chemistry


CO MA permeability assessment, 36 preclinical studies, 309
Add to Reading List

Document Date: 2013-08-23 07:13:50

Open Document

File Size: 57,63 KB

Share Result on Facebook

Company

Merck & Co / Ó 2010 John Wiley & Sons Inc. / LTS Lohmann Therapie-System AG / Bristol-Meyers Squibb Co. / Kos Pharmaceuticals Inc. / Pfizer Inc. / Perio Products Ltd / DepoMed / Alza Corporation / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

bilayer osmotic tablet processing / clinical applications / size-dependent technologies / printing techniques / bottom spray systems / preformulation/biopharmaceutical considerations / power coating systems / active pharmaceutical ingredient solubility / rotary spray systems / resonance imaging / cycle management / assisted floating systems / colon-specific drug delivery systems / free energy parameters / osmotic tablet technology / buccal drug delivery systems / floatable systems / life cycle management / corporate technologies / technology review / scale-up protocols / food effects / membrane systems / postapproval manufacturing / floatable gastric retention devices / extended release technology / imaging / bioadhesive controlled release systems / media properties / nonconventional systems / preformulation protocols / manufacturing process / magnetic systems / pharmaceutical equivalence / tablet technology / food effect / delivery port manufacturing / dry coating systems / food ingredients / spray systems / pharmaceutical ingredient / direct powder coating systems / generic vs. innovator products / retention devices / reservoir systems / printing / mucoadhesion systems / gastric retention devices / tablet technology classification / unconventional systems / fluidized bed coating systems / aqueous-base polymer coating systems / active pharmaceutical ingredient / bed coating systems / matrix technology / drug delivery systems / release systems / oil capsules / osmotic pump systems / pump devices / fluid bed coating systems / matrix systems / biopharmaceutical evaluation / osmotic delivery systems / oral release systems / manufacturing / veterinary applications / osmotic device / hybrid systems / colon-specific drug delivery device / gas-driven floatable systems / process analytical technology / polymer-based modified oral release systems / hydrophilic matrix systems / /

MedicalCondition

Inflammatory bowel disease / Periodontal disease / Disease / Dental caries / diseases / /

MedicalTreatment

drug delivery systems / drainage / /

Organization

Food and Drug Administration / EPC / RI AL / FDA / /

Person

Hong Wen / /

Product

Polyethylene glycol / Nifedipine / Naloxone / Metronidazole / Dv / Didanosine / Lactulose / Carvedilol / Exclusivity / /

Technology

122 Platform technologies / 212 extended release technology / sublimation / sorption / 144 DuraSolv technology / 194 size-dependent technologies / 327 preformulation protocols / 198 Lyoc technology / 24 SpansuleÒ technology / 165 Frosta technology / 162 Pharmaburst technology / 227 Multilayer matrix technology / Process Control / MRI / Chemical vapor deposition / 193 corporate technologies / pharmacokinetics / Ion exchange / process analytical technology / Laser / drug delivery / Biopharmaceuticals / Knowledge management / 162 FlashTab technology / Controlled Release Formulation / 259 OraSolv technology / Magnetic resonance imaging / osmotic tablet technology / 266 platform technologies / 163 preformulation protocols / 210 Flashdose technology / tablet technology / pharmacodynamics / simulation / 124 scale-up protocols / CVD / CAD / /

SocialTag